Cargando…

Management of patients at very high risk of osteoporotic fractures through sequential treatments

Osteoporosis care has evolved markedly over the last 50 years, such that there are now an established clinical definition, validated methods of fracture risk assessment and a range of effective pharmacological agents. Currently, bone-forming (anabolic) agents, in many countries, are used in those pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curtis, Elizabeth M., Reginster, Jean-Yves, Al-Daghri, Nasser, Biver, Emmanuel, Brandi, Maria Luisa, Cavalier, Etienne, Hadji, Peyman, Halbout, Philippe, Harvey, Nicholas C., Hiligsmann, Mickaël, Javaid, M. Kassim, Kanis, John A., Kaufman, Jean-Marc, Lamy, Olivier, Matijevic, Radmila, Perez, Adolfo Diez, Radermecker, Régis Pierre, Rosa, Mário Miguel, Thomas, Thierry, Thomasius, Friederike, Vlaskovska, Mila, Rizzoli, René, Cooper, Cyrus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076733/ https://www.ncbi.nlm.nih.gov/pubmed/35332506 http://dx.doi.org/10.1007/s40520-022-02100-4

Ejemplares similares

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
por: Hiligsmann, M., et al.
Publicado: (2019)

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Diez-Perez, Adolfo, et al.
Publicado: (2019)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures
por: Ethgen, Olivier, et al.
Publicado: (2015)

Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture
por: Ferrari, Serge, et al.
Publicado: (2016)

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: de Wit, Maarten, et al.
Publicado: (2019)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
por: Kanis, J. A., et al.
Publicado: (2017)

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
por: Chevalley, Thierry, et al.
Publicado: (2022)

FRI682 Cost Effectiveness Of Four Treatment Approaches For US Women And Men At Very High Risk Of Osteoporotic Fractures
por: Hiligsmann, Mickael, et al.
Publicado: (2023)

How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
por: Chevalley, T., et al.
Publicado: (2021)

Sarcopenia: burden and challenges for public health
por: Beaudart, Charlotte, et al.
Publicado: (2014)

The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2020)

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
por: Hadji, Peyman, et al.
Publicado: (2017)

Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures
por: Ethgen, O., et al.
Publicado: (2015)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations
por: Veronese, Nicola, et al.
Publicado: (2022)

Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment
por: Beaudart, C., et al.
Publicado: (2022)

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)
por: Cianferotti, Luisella, et al.
Publicado: (2017)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
por: Kanis, J. A., et al.
Publicado: (2019)

Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
por: Kanis, J.A., et al.
Publicado: (2020)

Health Technology Assessment in Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
por: Rizzoli, René, et al.
Publicado: (2011)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Dietary acrylamide and incident osteoporotic fractures: an 8-year prospective cohort study
por: Veronese, Nicola, et al.
Publicado: (2022)

A scoping review of the public health impact of vitamin D-fortified dairy products for fracture prevention
por: Hiligsmann, Mickael, et al.
Publicado: (2017)

Sarcopenia in daily practice: assessment and management
por: Beaudart, Charlotte, et al.
Publicado: (2016)

Intervention thresholds and diagnostic thresholds in the management of osteoporosis
por: Kanis, John A., et al.
Publicado: (2022)

Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
por: Ladang, Aurélie, et al.
Publicado: (2023)

Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
por: Ladang, Aurélie, et al.
Publicado: (2023)

English translation and validation of the SarQoL(®), a quality of life questionnaire specific for sarcopenia
por: Beaudart, Charlotte, et al.
Publicado: (2017)

Alternative and complementary therapies in osteoarthritis and cartilage repair
por: Fuggle, N. R., et al.
Publicado: (2020)

East meets West: current practices and policies in the management of musculoskeletal aging
por: Xia, Weibo, et al.
Publicado: (2019)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2018)

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2020)

Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France
por: Hiligsmann, M., et al.
Publicado: (2016)

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women
por: Neuprez, Audrey, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_kqqh2lfojjkor510797fg9ho1b